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Abstract
The application of magnetic nanoparticles for biomedical research is an interdisciplinary 
problem. The use of nano‐ and microsized powder materials as developed technology 
for obtaining bionanomaterials with magnetocatalytic properties has been investigated. 
Control over immobilization can be carried by means of magnetic properties. Synthesis 
of superparamagnetic nanoparticles is developed not only for the benefit of fundamental 
science, but also for many technologies, such as technologies of magnetic storage media, 
magnetic ink for printers, but mainly for biosensors and medical applications. All the 
biomedical applications require that the nanoparticles have high enough levels of satu‐
ration of magnetization; their size should be less than 100 nm with a small deviation in 
size. Appropriate coating of the surface of magnetic nanoparticles should be nontoxic, 
biocompatible with the target of bioorganic compound. The techniques of measurement 
of magnetic nanoparticle properties by means of vibrational magnetometers, as well as 
by means of a set of smart sensor devices in accordance with new concept of Internet of 
Things (IoTh), were described. The first method is based on vibrating sample magnetom‐
eter technique. The second method is based on direct measurement of three dimensions 
(3D) of nanoparticles’ magnetic field components.
Keywords: magnetic nanoparticles, drug transportation, magnetic field sensor
1. Introduction
Use of nanomaterials has become one of the innovation research directions in materials sci‐
ence, biochemistry and medicine. Small sizes of nanoparticles (NPs) lead to the appearance 
© 2018 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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of new unique functional properties. The methods of such material preparation are improv‐
ing every year and become more accessible. The technology of material structure “design” 
by combining different types of materials, starting from metals, their compounds (oxides, 
nitrides, borides and hydrides) and ending with organic and inorganic polymers [1], has 
recently been widely used. Nanomaterials based on metals operate in power generating, opti‐
cal industry and biomedicine. The unique superparamagnetic, optical and electrochemical 
properties are accentuated first of all. Use of magnetic nanoparticles (MNPs) for biomedi‐
cal researches is an interdisciplinary problem and to solve it experts in different areas are 
required—medical workers, biologists, specialists in the field of materials science and electro‐
dynamics. Application of nanomaterials with coating for biomedical purposes foresees such 
functional properties of the given system as adsorption, adhesion strength, biocompatibil‐
ity, and certain magnetic and optoelectronic properties that will identify the stability of the 
obtained structure‐energy state. The task of the materials science researchers is to develop 
complicated nanoobjects with optimal properties and morphological structure and to create 
the system of monitoring (Internet of Things (IoTh)) by their life activity cycle. The perfect 
biomedical systems can be considered such that the stable functional properties are possessed.
In particular, magnetism of nanoparticles is an important information carrier and what is 
especially valuable can be implemented through industrial means. This action at a distance 
in combination with a typical magnetic field penetration into human body tissues opens 
many new applications, including transport and purposeful delivery of biomagnets to a cor‐
responding biological object [2]. Magnetism can be exhibited in a greater number of new 
nanomaterials. It is known that, under transition to nanosizes in metals and their compounds, 
new specific characteristics appear. Thus, magnetic properties of bulk gold and platinum are 
nonmagnetic, but at the nanosize they are magnetic. Surface atoms are not only different to 
bulk atoms, but they can also be modified by interaction with other chemical species, that is, 
by capping the nanoparticles. This phenomenon opens the possibility to modify the physi‐
cal properties of the nanoparticles by capping them with appropriate molecules. Actually, it 
should be possible that nonferromagnetic bulk materials exhibit ferromagnetic‐like behavior 
when prepared in a nanorange. One can obtain magnetic nanoparticles of Pd, Pt and the 
surprising case of Au (that is diamagnetic in bulk) from nonmagnetic bulk materials. In the 
case of Pt and Pd we can obtain the ferromagnetism. However, gold nanoparticles become 
ferromagnetic when they are capped with appropriate molecules: the charge localized at the 
particle surface gives rise to ferromagnetic‐like behavior. This observation suggested that 
modification of the d band structure by chemical bonding can induce ferromagnetic‐like char‐
acter in metallic clusters [3].
2. Use of magnetic nanoparticles in medicine
Magnetic biomaterials are widely used in medicine, especially in cardiology, neurosurgery, 
oncology, radiology and cellular biology for cell separation, to perform immunological 
analysis, magnetic resonance spectroscopy, information preservation and so on [1–8]. They 
are also used as the X‐ray contrast means and magnetosensitive composites for drugs and 
genes delivery, in radionuclide therapy and hyperthermia (Figure 1). Such applications are 
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perspective in case the clearly defined and checked interaction between magnetic nanopar‐
ticles and living cells is provided.
It is known that living organisms are built of cells with usual sizes of about 10 μm. The objects 
from which a cell consists of are much less than 1 μm. It should be considered that the syn‐
thesized nanoparticles are of sizes 2–450 nm, commensurable with the sizes of intercellular 
biological objects, viruses, proteins and genes. Thus, the nanoparticles by the sizes and mass 
occupy the intermediate place between single molecule and living cells. Still the main advan‐
tage of these materials is their ability to perform the preset functions under the effect of exter‐
nal magnetic field (Figure 2).
This occurs due to the formation of potential barriers at their boundary that limit the charge 
carrier movement in different directions and give the electron processes a mainly quantum 
character with dominating role of the interface. It should be noted that in this case a non‐
linear dependence of equilibrium concentration of defects at the interface is observed that 
increases the dependence of properties on nanostructure sizes [10]. This is especially impor‐
tant when delivering drugs and means of diagnostics. Depending on the sizes, other proper‐
ties of nanoparticles as toxicity, adsorption ability and magnetism also change. In particular, 
when the size of nanoparticles is less than 10 nm, they pass into a superparamagnetic state 
that, when adsorbing the energy of the external high‐frequency electromagnetic field, pro‐
motes conversion of the energy state into the thermal one. This enables a tumor heating to a 
temperature of 43°С and thus its destruction [11, 12].
Figure 1. Use of magnetic nanoparticles in medicine.
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It has recently been proven that the effects of heat are more cytotoxic for cancer cells than 
they are for surrounding normal cells. Because of this, researchers have focused on hyper‐
thermia as a method to selectively treat cancer cells. In Gilchrist's invaluable study, the cancer 
cells were heated locally using magnetic NP with a 1.2‐MHz magnetic field. Since then, other 
observations have demonstrated that magnetic‐induced hyperthermia in animals that have 
been injected directly with MNP can produce tumor regression through the application of 
magnetic fields to the solid tumors [9].
For therapeutic aims, magnetic nanoparticles are rarely used in a pure form. Usually, they 
are encapsulated or situated in bioinert matrices made of different organic compounds 
(Figure 3). This allows decreasing of the possible toxic effect of magnetic phase and simul‐
taneous increasing of its stability due to immobilization on the surface of such capsules or 
matrices of medical aids. Encapsulation is usually carried out in suspensions of ultradisper‐
sive ferromagnetic or superparamagnetic particles containing stabilizing reagents—so called 
magnetic liquids [2, 5].
The structure of a multifunctional/multimodality MNP with a magnetic core, a polymeric 
coating and targeting ligands extended from the surface of MNP with the aid of polymeric 
spacers. Therapeutic payloads (drugs and genes) and imaging reporters (fluorophores and 
radionuclides) can be either embedded in the coating, or conjugated on the surface [5].
Magnetic contrast agents using which an image of a human body is obtained with a nuclear 
magnetic resonance tomography are widely known. Particles of these agents consist of a core 
Figure 2. Several classes of NP used for the design of smart micro/nanocarriers, including micelles, dendrimers, 
nanocages, CNT, polymeric conjugates, nanogels, magnetic NP, quantum dots (QD), nanospheres and gold (Au) NP [9].
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form magnetite or maghemite and a shell from dextran or silicon. Colloid solutions based on 
biomolecule‐sorbed magnetic iron oxides, surrounded by a polymer layer, can be used for 
interaction with biological targets and direct them into a tumor with the aim of treatment 
or diagnostics. In this case, the controlled movement of magnetic particles in a body occurs 
because of the use of magnetic field gradient, regulated such that particles penetrate directly 
into the affected area [4].
Magnetic nanoparticle‐based drugs can be divided into two groups: for external use (oint‐
ments, applicators, etc.) and for internal use (liquids, suspensions and magnetic containers). 
To improve physicochemical and medical biological properties when delivering drugs, the 
sizes of magnetic material particles in the blood stream should not exceed 100 nm. Under 
such conditions, they can be also used for hypoferritic anemia treatment. Today, the drugs 
obtained by adding precious metals to iron are paid more and more attention to. They are 
used as anti‐inflammatory, antibacterial, anticancer and anesthetic compounds of the oint‐
ments for external use.
Magnetic carriers of medical purpose should be biocompatible with a human organism, non‐
toxic and nonallergenic. To improve biocompatibility, magnetic carriers are coated with chi‐
tosan, dextran, starch, carbon, gelatin, polymer starch coatings and so on (Figure 4). It should 
be noted that silicon oxide also increases biocompatibility of nanoparticles, and in this case, 
iron is localized inside the SiO
2
 particles as in microcapsule. Release rate of drugs in these 
conditions can be regulated by changing the size and porosity of the obtained systems [4].
Recently, nano‐ and microsize powder materials are based on Fe
3
O
4
, especially in combi‐
nation with bioselective elements—ferments have been widely used. This is important for 
developing technologies of manufacturing bionanomaterials with catalytic properties. High 
chemical activity of Fe
3
O
4
particles is caused by their higher ability to ion or atomic exchange, 
adsorption and formation of surface ligaments with other adsorbed particles. This guarantees 
Figure 3. Graphic illustration of the structure of a multifunctional/multimodality MNP and different types of magnetic 
cores.
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the creation of bioparticles (immobilized ferments on the particle surface) with their further 
use in biosensorics and in enzymatic reactions. It is known that powder particles of Fe
3
O
4
 
retain magnetization even if no external magnetic field is present, possessing own magnetic 
moment. However, remaining magnetization has a negative effect—a tendency of nanopar‐
ticles to agglomeration. Therefore, for the effective use of such magnetic particles, their chemi‐
cal stability should be ensured by applying the corresponding coating on their surface.
2.1. Methods of obtaining magnetic nanoparticles
Physical and chemical properties of magnetic nanoparticles are determined by their structure 
and method of preparation. In most cases, these are particles of size from 1 to 100 nm with 
clearly expressed superparamagnetism. The most widely used methods of magnetic nanopar‐
ticle synthesis are as follows:
• Deposition—synthesis of iron oxides from water solutions of their salts in inert gas atmo‐
sphere at ambient or elevated temperature.
• Thermal decomposition—synthesis of Fe
3
O
4
 nanoparticles during decomposition of or‐
ganic metal compounds in boiling organic solvents that contain stabilizing surface active 
agents (SAA).
• Microemulsion technology.
To synthesize magnetite‐based nanocomposites, the following methodical approaches are 
mainly used [13–16].
Figure 4. Schematic representation of the proposed magnetic sensitive carrier and triggered drug release mechanism [9].
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• Precipitation in the conditions of oxidizing hydrolysis of iron sulfate Fe2+ in acid 
environment.
• Precipitation in the conditions of alkali hydrolysis of iron chlorides Fe2+ and Fe3+.
• Precipitate deposition from the solutions of iron chlorides Fe2+ and Fe3+ under alkali hydro‐
lysis of urea.
When modifying the conditions of magnetite core synthesis and forming the core shell, it is 
possible to obtain magnetic nanocomposites that differ not only by size but also by the ratio 
of “core–shell” sizes, magnetic susceptibility and complexity of surface microrelief that will 
specify the absorption properties.
However, nanoparticle synthesis has remained until now a complicated task. This is related 
with the difficulty of formation of homodispersive population of checked‐size magnetic par‐
ticles. It should be noted that there is no still a complete understanding of the mechanisms 
of core formation and growth. Besides the technology of obtaining crystalline nanoparticles 
with high saturation, magnetization needs further improvement. Moreover, nanoparticles 
lose their stability with time. This occurs due to the decrease of their free surface energy as a 
result of agglomeration. It is necessary to develop strategies of the surface coating preparation 
to simplify the process and effectively prevent agglomeration and segmentation of superpara‐
magnetic particles. As a result, a stable solution for injections or frozen‐dried (lyophilized) 
powder, that is easily dissolved, can be obtained [17].
Investigation of superparamagnetic nanoparticles, especially Fe
3
O
4
 nanoparticles, should 
be aimed at establishing the interrelations between their structure and pharmacokinetics. 
Nature of the coating on the iron oxide surface will determine not only the size of colloids but 
also will affect the pharmacokinetics and metabolic properties. This will enable modeling of 
their capture by reticuloendothelial system (RES) and facilitate diffusion to the tumor tissue. 
Processes of modification of magnetic nanoparticle surface, which are used for connection 
of biovectors, must be also improved. This is decisive in optimization of superparamagnetic 
nanoparticles likeness with biological objects [18].
2.2. Properties of Fe
3
O
4
 magnetite
Iron oxides (in particular magnetite) are among the most investigated materials in human 
history. Synthesis of superparamagnetic nanoparticles of iron oxide Fe
3
O
4
 is developing for 
the sake of fundamental science and technological applications, as for example magnetic data 
carriers, for biosensor, medical applications and magnetic inks [19–21]. Superparamagnetic 
nanoparticles of iron oxide with corresponding surface microgeometry can be used for 
increasing the image contrast, restoration of tissues, detoxification of biological fluids, hyper‐
thermia, directed delivery of drugs and cell separation.
Detailed characterization of magnetite NPs is therefore necessary in order to obtain an accurate 
relationship between their electronic, magnetic and structural properties. Nominally claimed 
magnetite NPs are often (and to various extents) composed of nonstoichiometric oxide phases, 
and their instability in air ultimately causes oxidation to maghemite. The oxidization rate of 
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magnetite NPs in ambient conditions is size‐dependent and can range from several months 
for NPs <10 nm, up to several years for NPs ∼100 nm. However, there is no general con‐
sensus regarding the complex oxidation mechanism, which presumably proceeds through a 
continual set of intermediate phases accompanied by cations and vacancies (C–V) reordering. 
Magnetite and maghemite both crystallize in the face‐centered cubic (fcc) spinel structure, 
whose unit cell is composed of 32 O2− ions placed at the 32e crystallographic position, and 24 
Fe ions distributed over the 64 tetrahedral 8a (A) and 32 octahedral 16d (B) crystallographic 
positions (Figure 5). Magnetite and maghemite can be represented with a single formula: 
(Fe3+)
A
[(Fe2+)1–3δ(Fe
3+)1+2δ δ]BO
4, where stands for vacancies and 0 ≤ δ ≤1/3. In pure magnetite 
(δ = 0), all A sites are occupied by Fe3+ ions, while B sites are equally occupied with Fe2+ and Fe3+. 
In pure maghemite (δ = 1/3), all Fe ions are in 3+ state, with a tendency to regular arrangement 
Figure 5. Left: monoclinic crystal structure of Fe
3
O
4
 in the low‐temperature phase corresponding to a subcell of a2×a2×2a 
with P2/c symmetry. Right: 3D isosurfaces of unoccupied density of states of the O 2p integrated between the fermi level 
and 1 eV above within the corresponding Fe
3
O
4
 cubes highlighted in the crystal structure. For simplicity, we denote the 
octahedral Fe site with nominal 2+ and 3+ valences as Fe2+ and Fe3+, respectively [22].
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at B sites (two occupied followed by one vacant site). Vacancies occur preferentially at octahe‐
dral sites, but they can also mix over octahedral and tetrahedral sites. The degree of vacancy 
ordering in maghemite decreases with a particle size, and it is believed that for NPs smaller 
than 20 nm vacancy ordering vanishes. Magnetite and maghemite are both ferrimagnetic (the 
two uneven ferromagnetic sublattices Fe
A
 and Fe
B
 are antiferromagnetically aligned), with 
comparable saturation magnetizations (MS = 90 emu/g for magnetite; MS = 83.5 emu/g for 
well‐ordered crystalline maghemite samples) and extraordinary high Curie temperatures (TC 
= 858 K magnetite; TC = 790–893 K maghemite, depending on the degree of C–V ordering).
The important difference between magnetite and maghemite is that maghemite is an insulator 
with energy gap Eg ≈ 2 eV, while magnetite is half‐metal with much narrower Eg = 0.1–0.5 eV 
(depending on the sample quality). Furthermore, bulk magnetite undergoes so‐called Verwey 
order‐disorder phase transition to the insulating state at temperatures 120–125 K, accompa‐
nied with structural change from cubic to monoclinic lattice symmetry and various anomalies 
in the physical properties. The decisive influence on this complex transformation is ascribed 
to charge and orbital ordering involved in the three‐site distortions. The exact structural 
parameters of the low temperature (LT) crystal structure, which is thought to have at least 
four inequivalent octahedral Fe sites, are extremely difficult to determine.
Things are even more elusive when the sample size is in the nanometer range. According to 
some recent reports for NPs with the mean size ~ 50 nm, the Verwey temperature (TV) shifts 
down to 20 K and it cannot be observed for smaller particles. The Verwey transition is weakly 
size‐dependent in magnetite NPs larger than 20 nm, slightly suppressed in NPs smaller than 
20 nm, and completely vanishes for NPs smaller than 6 nm. These inconsistencies are often 
ascribed to the fact that final properties of magnetite NPs strongly depend also on structural 
order [23].
2.3. Investigation of the structure and properties of Fe
3
O
4
 nanoparticles
In this research, the Fe
3
O
4
–NP characterization was performed by infrared Fourier spectroscopy 
using spectrophotometer Bruker Vertex 70 with attachment attenuated total reflectance (ATR). 
Powder samples were dried on the microscope slide surface and irradiated by a laser beam.
The intensive peak from Fe
3
O
4
‐NP at 600 cm−1, similarly to micro X‐ray spectral analysis, indi‐
cated the presence of Fe‐O bonds in Fe
3
O
4
–NP (Figure 6, Table 1). Peak intensity increases 
from the value of 1200 сm−1, and in the range of 600–1200 cm−1 a significant background of the 
wave number area of the substances of glass on which the samples were dried is observed. 
In this range, only a signal from Si‐O (for a wave number 1053 cm−1) is clearly seen. The blind 
area should contain signals from C‐O (for a wave number of about 1100 cm−1) and signals of 
group Si–O–C (for a wave number of about 1108 cm−1).
Obtained data can be used as an introductory information for processing monitoring of 
dynamics in situ of nanoparticle modification.
Size of Fe
3
O
4
 particles strongly affects its microstructure and properties. Figure 7 presents a 
difference in microstructure of Fe
3
O
4
 micro‐ and nanoparticles.
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To estimate the sizes of Fe
3
O
4
‐NP atomic‐force microscopy was used, which software prod‐
ucts allowed the establishment of the scanned particle structure (Figure 8). Investigation data 
prove the results of microscopic investigations on the spherical nanoparticle accumulation. 
Two types of structural inhomogeneity can be distinguished on the investigated sample sur‐
face: conglomerates of conical‐like nanoparticles and granular texture of substrate. Surface 
topography is characterized by a rough relief with morphological regions of blocked struc‐
ture. Blocks are characterized by nonisometric round form with no surface faceting. Their 
height above the substrate surface is in the range from 5 to 10 nm and base diameter from 30 
to 50 nm. In this case, the dominant size of nanoparticles is 8 nm.
It is established at the same time that the size of Fe
3
O
4
microparticles is about 1μm (Figure 9(b)).
Use of Fe
3
O
4
nanoparticles with the aim of their functionalization (application of shells, medi‐
cal aids and markers on them) or introduction in a living organism for hyperthermia foresees 
the application of surface coating. In this case, the analysis of the dimensions and properties 
of nanoparticles using a simple method becomes more complex [24]. In such cases, magnetic 
methods become one of the methods of particle categorization.
2.4. Methods of magnetic properties investigation
Among the magnetic research methods in materials science, the magnetic phase analysis is 
especially widely used. Its possibilities and effectiveness to a great extent are determined 
Figure 6. ІR‐Fourier spectra of Fe
3
O
4
 nanoparticles.
Wave number (cm−1) Chemical bond
3230 ‐OH valence vibrations
1617 ‐OH deformation (“wagging”)
1421 Not described
600 Fe‐O
Table 1. Correspondence of IR‐Fourier spectra peaks of Fe
3
O
4
–NP to chemical bonds [13–16].
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by technical characteristics of the equipment. The quantitative phase magnetic analysis uses 
properties of ferromagnetics, which they acquire in strong magnetic fields—in the state of 
technical saturation. Primary magnetic properties that are structurally insensitive are obtained 
from the curve of temperature dependence of saturation magnetization. Such characteristics 
are magnetization and Curie point. These values give the information about phase composi‐
tion of material and its changes in the process of certain thermal operations and also in the 
process of deformation. Curie point and saturation magnetization are called primary mag‐
netic properties because their values are determined by the nature of the ferromagnetic phase 
(crystal lattice, electron structure of atoms and chemical phase composition) [25].
Changes in magnetization and Curie point of separate phases observed in the process of inves‐
tigation of a certain material are not caused by their particle growth but are conditioned by 
the change of chemical composition of phases and their crystalline composition only. Based 
on these data, it is possible to study the kinetics of phase formation at the very early stages of 
the process (for particles sizes up to 10−6 cm) by the growth of magnetization and Curie point 
to their normal values. Thus, a weak dependence of saturation magnetization and Curie point 
Figure 7. Microstructure of synthesized Fe
3
O
4
: (а) Fe
3
O
4
 nanoparticles; (b) Fe
3
O
4
 microparticles. Microstructures were 
obtained according to the scanning microscopy data.
Figure 8. Character of distribution of synthesized Fe
3
O
4
‐NP on the surface (a) and histogram of their distribution by 
size (b). Lateral dimension of particles in nanometers is given on X‐axis, and a number of scanned particles on Y‐axis.
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on the stress state, form and degree of ferromagnetic dispersion allows us to choose these 
physical parameters as the quality characteristics of phases. Just these factors that strongly 
affect the results of the quantitative X‐ray analysis, in the magnetic phase analysis, practically 
have no effect on the investigation results.
To carry out magnetic phase analysis, it is necessary to build experimentally a temperature 
dependence of saturation magnetization of the tested material sample. Equipment for the analy‐
sis should provide measuring of magnetic properties in a wide range of temperatures and heat‐
ing and cooling rates. Peculiarity of the determination of the transition temperature of a number 
of dispersive magnetic systems to the paramagnetic state is that their magnetic phase analysis 
must be performed at high heating rates. Since in a number of cases the mass of the investigated 
samples can be very small (nanomaterials, fine‐dispersive powders, amorphous films, surface 
layers after different types of heat treatment) and as a result the value of the magnetic moment 
is relatively small (from 10−2 to 10−3 А·м2), the equipment must possess a very high sensitivity.
For such investigations, it is most reasonable to use the method of vibrating specimen that is 
realized through vibration magnetometers [26].
Measurement accuracy with vibration magnetometer depends on the calibration accuracy. 
We have proposed the method of comparison when magnetometer is calibrated using a stan‐
dard with a known magnetic moment. As a standard, carbonyl iron of certain batches is used.
Application of the comparative method for calibration requires ensuring of the following 
conditions:
• insignificant changes in the position and deviation from the perfect sphere‐like symmetry 
have no influence on a calibration constant;
• frequency and amplitude of vibrations remain constant;
• sample holder (container) introduces only an insignificant value to the signal value and can 
be subtracted from it; and
• signal voltage—linear function of the magnetic moment of the sample.
Figure 9. Character of distribution of synthesized microparticles of Fe
3
O
4
(а) and histogram of their distribution by size 
(b). Transverse dimension of particles in nanometers is given on X‐axis, and a number of scanned particles on Y‐axis (b).
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Two measuring methods are used in vibration magnetometers—direct or compensation. The 
last one, in its turn, is of two types: the method of current shell and differential method. 
Compensation method allows avoiding the dependence of measuring results on the values 
of amplitude and frequency of vibrations. It is optimal to perform high‐temperature mea‐
suring preliminary assuming the measures of stabilization of sample mechanical vibration. 
Constant amplitude and frequency of sample vibrations is a required condition of providing 
an adequate accuracy of measuring by the direct method.
The main cause of vibration amplitude instability is the changes in the moving parts of the 
magnetometer. Stability of measuring parameters is determined, in addition, by the stability 
of the alternating current generator which feeds the vibrator. Vibration amplitude stabiliza‐
tion was realized by providing a negative feedback of the generator.
Such a device for investigation of the magnetic properties possesses a number of unique char‐
acteristics. At room temperature, it is possible to build a hysteresis loop, partial hysteresis 
loops, initial curves of magnetization and demagnetization, and dependence of a magnetic 
moment on the sample orientation. At elevated temperatures, thermomagnetic measure‐
ments, high‐temperature hysteresis measurements, and time dependences of magnetic 
moment at different temperatures can be carried out. Temperature measuring interval ranges 
from 80 to 1100 K at power 3.5 кWt. Magnetic measurement in this work was performed using 
a vibration magnetometer [15]. Curves of the investigated samples over magnetization were 
recorded in magnetic fields from −200 кА/m to +200 кА/m by measuring the dependence of 
the given magnetization І/І
200
on the magnetic field strength Н, І
200
—magnetization at mag‐
netic field strength 200 кА/m.
As one can see, curves of Fe
3
O
4
‐NP sample remagnetization have a nonhysteresis form with 
a zero coercive force Нс and residual magnetization Іr (Figure 10(а)). Probably particles of 
Fe
3
O
4
 due to a high degree of dispersivity are in a superparamagnetic state—state that is 
typical of microscopic and nanoscopic particles of ferromagnetic materials. In this case, a 
magnetic moment of the like particle changes its orientation spontaneously and randomly 
or due to thermal fluctuations. When external magnetic field is absent, superparamagnetics 
Figure 10. Curves of remagnetization of Fe
3
O
4
‐NP (а) and Fe
3
O
4
‐MP (b) samples.
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have on average a zero magnetic moment, i.e., they behave like paramagnetics with a high 
magnetic susceptibility. As known, superparamagnetic properties of Fe
3
O
4
 particles at room 
temperature are exhibited, when reaching an average diameter D < 25 nm. In our case, the 
particles size is 5–10 nm.
With increasing sizes of Fe
3
O
4
 particles to microsizes, the magnetic properties do not 
change. These particles have already a hysteresis loop (Figure 10(b)). Samples’ coercive 
force is Нс =4 кА/m, and ratio is І/І200=0.1.
2.5. Use of the Internet of Things to measure of magnetic properties
For a remote study of magnetic properties of nanoparticles, it is proposed in this work to use 
the approaches of the Internet of Things—a network that consists of the interrelated physi‐
cal objects or devices that contain mounted gauges. Their software allows one to pass and 
exchange data between physical world and computer systems using the conventional proce‐
dure of communication. In addition to gauges, the network contains executing devices, built‐
in physical objects interrelated by wire or wireless nets. These interrelated objects possess 
function of reading, putting in operation, programming and identification of objects and also 
allow one to exclude the necessity of person participation due to application of the intellectual 
interfaces.
Technology of magnetic particle detection and characterization is based on many approaches 
of magnetic sensing techniques [27, 28].
Here we present novel 3D magnetic sensors which offer three‐dimensional sensing of orthog‐
onal B
X
, B
Y
, and B
Z
 projections of magnetic field vector. Nowadays, many types of techniques 
and magnetic sensors provide such possibility [29, 30]. Among them, three types, namely 
magnetoresistors, Hall sensors and magnetotransistors, are preferable.
The first type, magnetoresistors, is based on the effect of magnetoresistance which is a ten‐
dency of material to change the value of its electrical resistance in an externally applied mag‐
netic field. There are a variety of effects that can be called magnetoresistance: some occur 
in bulk nonmagnetic metals and semiconductors, such as geometrical magnetoresistance, 
Shubnikov de Haas oscillations, or the common positive magnetoresistance in metals. Other 
effects occur in magnetic metals, such as negative magnetoresistance in ferromagnets or 
anisotropic magnetoresistance (AMR). Finally, in multicomponent or multilayer systems 
(e.g., magnetic tunnel junctions), giant magnetoresistance, tunnel magnetoresistance and 
extraordinary magnetoresistance can be observed [31].
As an example, Honeywell International Inc. produced a series of magnetic sensors based on 
anisotropic magnetoresistance effect. AMR is a property of material in which the dependence 
of electrical resistance on the angle between the direction of electric current and the direction 
of magnetization is observed. AMR arises from the simultaneous action of magnetization and 
spin‐orbit interaction, and its mechanism depends on the material. It can be for example due 
to a larger probability of s‐d scattering of electrons in the direction of magnetization, which is 
controlled by the applied magnetic field.
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AMR technology provides advantages over other magnetic sensor technologies. These aniso‐
tropic, directional sensors feature precision in‐axis sensitivity, linearity, and low cross‐axis 
sensitivity. For example, the HMC5883L is a small‐size surface‐mount, multi‐chip module 
designed for low‐field 3D magnetic sensing with a digital interface for applications such as 
low‐cost compassing and magnetometry. The HMC5883L includes the state‐of‐the‐art, high‐
resolution HMC118X series magnetoresistive sensors plus an application‐specific integrated 
circuit, containing amplification, automatic degaussing strap drivers, offset cancellation and 
a 12‐bit analog‐to‐digit converter.
The second type, Hall sensors, is based on Hall effect which is due to the nature of the current in 
a conductor. Current consists of the movement of many small charge carriers, typically electrons, 
holes or ions. When magnetic field is present, these charges experience a force, called the Lorentz 
force. When such a magnetic field is absent, the charges follow approximately straight “line of 
sight” paths between collisions with impurities, phonons and so on. However, when a magnetic 
field with a perpendicular component is applied, their paths between collisions are curved so 
that moving charges accumulate on one face of the material. This leaves equal and opposite 
charges exposed on the other face where there is a scarcity of mobile charges. The result is an 
asymmetric distribution of charge density across the Hall element, arising from the force that is 
perpendicular to both the “line of sight” path and the applied magnetic field. The separation of 
charge establishes an electric field that opposes the migration of further charge, so a steady elec‐
trical potential is established for as long as the charge is flowing.
We have proposed new type of thin‐film magnetic field sensors for three‐dimensional sensing 
of orthogonal B
X
, B
Y
 and B
Z
 projection of magnetic field vector [32–37], new method for mea‐
suring magnetic field [38] as well as their modeling and signal processing [39–44].
The general view of such thin‐film 3D sensors, its active area, structure and photographs 
are presented in Figures 11–13, correspondingly. The sensor (Figure 12(a)) active area is the 
thin sensitive semiconductor film (2) of corresponding configuration formed at the semi‐insu‐
lating GaAs substrate (1). Sensor contacts are formed by the metallization layer (3), which 
typically is the gold film together with other metals, for example, with titanium sublayer. For 
manufacturing of the structures, three photolithographies are used. The first one is intended 
Figure 11. General view of thin film 3D sensors (a) and its active area (b).
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for creation of the contact system (Figure 12(b)); the second one is for etching a semiconductor 
film into the whole depth (Figure 12(c)); and the third one is for etching the semiconductor 
film to approximately 10% of their thickness (Figure 12(d)).
To show how a 3D thin‐film sensor works, let us consider its main component—transducer #1 
(Figure 14). The magnetic field vector projections B
X
, B
Y
 are located in the transducer plane, 
and B
Z
 projection is perpendicular to this plane.
The operation principle of transducer of type #1 is the following: transducer is connected 
to the power source, typically direct current source; for this, the central current contact 3 
is connected to the first power supply output, and side current outputs 4, 5 are connected 
together to the second power supply output. Thus, the current in the active area of the 
transducer is divided equally and run in mutually antithetical directions in relation to the 
current output.
Neglecting the current in the 6 and 7 voltage contacts’ circuit, one may consider that the volt‐
ages at those outputs are equal to the corresponding voltages of the intermediate areas 10 and 
Figure 13. Photos of 3D thin‐film sensors: wafer (a), chip (b) and active area (c).
Figure 12. Structure and its formation stages (a), (b), (c), (d) of 3D thin film sensor: 1—substrate, 2—semiconductor active 
area; 3—contact metallization layer.
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11. So the construction of the type #1 transducer provides the possibility of forming the output 
voltage at the 6 and 7 voltage contacts, which is equal to the voltage difference between the 
areas of lower surface of the active area in the neighborhood for the contacting to the inter‐
mediate areas 10 and 11. The voltage measurement at the areas of lower active area surface is 
obvious that the thickness of intermediate areas 10, 11 was considerably thinner (at least 10 
times) than the thickness of active area 2.
The principal difference of the type #1 transducer from analogs, for example Refs. [29, 30], is 
that in the first one the voltage difference is measured between the areas of lower active area 
surface, and in the analogs—between the areas of the upper active area surface. In its turn, 
the absence of contacts with the upper active area surface makes it possible not to perform the 
active area surface insulation.
In general case, the voltages at the voltage outputs 6, 7 are composed of three components. 
The first component V
R
 is caused by the voltage drop at the semiconductor active area 2. 
Taking into consideration the symmetry of the active area in relation to the first current con‐
tact 3, the first voltage component at both voltage contacts 6, 7 is equal V
R
(6) = V
R
(7). The sec‐
ond component V
Z
 is caused by the influence of B
Z
 magnetic field vector projection, which is 
perpendicular to the transducer plane. Taking into consideration the transducer construction 
and current flow directions in it, the second voltage component at the voltage contacts 6 and 7 
is also equal V
Z
(6) = V
Z
(7). The third component V
X
 is caused by the influence of B
X
 projection 
Figure 14. Structure of type #1 transducer: 1—substrate, 2—semiconductor active area; 3—central current contact; 4, 5—
side current contacts; 6, 7—voltage contacts; 8, 9—auxiliary areas; 10, 11—intermediate areas.
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of induction vector. Contrary to the two stated above, this component at the voltage contacts 
6 and 7 has the opposite signs V
X
(6) = −V
X
(7). In particular, in the upper part of active area, 
two charge carriers under the influence of electromotive force deviated to the upper semi‐
conductor layer surface, and then, in the lower part—to the lower surface (in the direction of 
substrate). The voltage difference caused by this carrier deviation is transferred to the voltage 
contacts 6 and 7 through the intermediate areas 10 and 11. It is to be noted that the B
Y
 magnetic 
field induction vector projection, parallel to the direction of current flow through the active 
area, does not cause the carrier deviation, and therefore, it may be neglected: V
Y
(6) = V
Y
(7) = 0.
Thus, the voltage difference between the voltage outputs 6 and 7 (output voltage of type#1 
transducer) is determined only by B
X
 magnetic field induction vector projection, and in first 
approximation, it does not depend on other vector projections:
  V 
OUT
    =   [ V R ( 6 ) +  V X ( 6 ) +  V Y ( 6 ) +  V Z ( 6 ) ]  – [ V R ( 7 ) +  V X ( 7 ) +  V Y ( 7 ) +  V Z ( 7 ) ]   =    V X , (1)
where V
X
 = V
X
(6)+V
X
(7).
The especially high efficiency of transducer of type#1 application is realized in case of their 
application in 3D sensor for simultaneous measurement of three projections B
X
, B
Y
 and B
Z
 of 
the magnetic field induction vector. Such 3D sensor contains three coupled transducers at a 
single substrate. The construction of two transducers of #1 type is similar to Figure 14. They 
are mutually orthogonally rotated and provide the sensitivity to the BX, BY vector projections 
of the field induction vector. The third transducer, which provides the sensitivity to the BZ 
projection, is a traditional Hall transducer [29].
To provide the equal sensitivity levels for all three transducers of such 3D sensor, it is neces‐
sary to take into account the following: contrary to the traditional Hall transducers, which 
have the sensitivity as an inverse function of semiconductor active layer thickness d, the sen‐
sitivity of the transducer of type #1 is inversely proportional function of the semiconductor 
area width W. So it is recommended that the active area width W should be minimal and 
approximately equal to the semiconductor layer thickness d.
There are two other options to build up 3D magnetic thin film sensors. They are based on type 
#2 and type #3 transducers.
The structure of type #2 transducer is shown in Figure 15.
The type #2 transducer is fed by the direct current source, and one pair of mutually opposed 
current contacts (e.g., 3 and 5) is connected to one output of the power source (e.g., positive), 
and another pair (4 and 6 correspondently) to the other power source contact (negative, cor‐
respondently). In accordance with this connection scheme, the four current flow circuits are 
formed: I
34
, I
36
, I
54
 and I
56
, where the indices in the marked currents correspond to the numbers 
of current contacts. These current flow circuits geometrically form the square sides. The mat‐
ter of principal importance is that the currents that flow in opposed square sides are equal 
by value and opposed by sign:  
→
 I 
34
 = −  → I 
65
;    → I 
36
 = −  → I 
45
. The output signal of transducer is the voltage 
difference between the voltage contacts. The informative signals about the magnetic field vector 
projections B
X
, B
Y
, B
Z
 are the voltages V
X
, V
Y
, V
Z
, which in first approximation are determined as:
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  V 
X
  =  V 
8
 −  V 
10
 ;    V 
Y
  =  V 
7
 −  V 
9
 ;    V 
Z
  =  { ( V 8 −  V 9  ) +( V 10 −  V 7  ) }  / 2 (2)
The difference of type #2 transducer from its analog [29, 30] is the limitation of the area of cur‐
rent transition between the 2nd outer and 11 inner insulating areas. This provides the increase 
of the sensor sensitivity to the B
X
, B
Y
 magnetic fields and decreases the cross‐impact between 
the informative signals.
The sensitivity increase is explained by the reduction of the transducer active area size. 
Contrary to the traditional Hall transducers (sensitive to the field B
Z
 perpendicular to the 
transducer plane), where the size that determines the sensitivity is the active area thickness, 
in case of the B
X
, B
Y
 field transducers, the determinative size is the current scattering region. 
The smaller area occupies the current scattering region, the higher is the voltage difference 
between the two corresponding voltage contacts, and therefore the higher sensitivity is.
The structure of type #3 transducer is shown in Figure 16.
Arms 2, 4 and contacts 6, 8, 10, 12 form the first vertical Hall transducer, and arms 3, 5 and 
contacts 7, 9, 11, 13—the second vertical Hall transducer. The first transducer is intended for 
measuring the B
X
 magnetic field vector projection, and the second one—for measurement of 
B
Y
 projection. The measurement principle of Hall transducers consists in forming the voltage 
difference at the voltage outputs during the deviation of charge carriers in the semiconductor 
area under the electromotive force influence.
Figure 15. Structure of type #2 transducer: 1—semiconductor active area; 2—outer insulating area; 3, 4, 5, 6—current 
contacts; 7, 8, 9, 10—voltage contacts; and 11—inner insulating area.
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The operation of type #3 transducer presumes two power supplying modes. The first one 
provides the operation of the vertical Hall transducers, and the second one for operation of 
the horizontal one.
The first power‐supplying mode presumes the connecting of the current contacts of the verti‐
cal Hall transducers, when the currents in their semiconductor areas are flowing in mutu‐
ally opposed directions. For this, the current contacts of both vertical Hall transducers are 
connected into one circuit. Namely, contacts 6 and 8 of the first vertical Hall transducer are 
connected together and to the first, for example, positive output of the power source, and 
contacts 7 and 9 of the second vertical Hall transducer are also connected together to the sec‐
ond, therefore, negative output of the power source. So, in the first vertical Hall transducer, 
the currents are flowing from the top to the bottom (current I
2
 in arm 2) and from the bottom 
to the top (current I
4
 in arm 4), and in the second—from left to right (current I
3
in arm 3) and 
from right to left (current I
5
 in arm 5). In case of ideal symmetry of the transducer structure, 
the following equality takes place:  
→
 I  = −  → I ;  → I  = −  → I .
Output signals of vertical Hall transducers are formed at the voltage outputs as a voltage dif‐
ference, which is proportional to the multiplication of the power supply current value of the 
transducer by the corresponding magnetic field vector projection:
  V 
X
    =  V ( 12 )  – V ( 10 )   =    K 
X
 × I ×  B 
X 
  /  W–for the first transducer and (3)
and
  V 
X
    =  V ( 12 )  – V ( 10 )   =    K 
X
 × I ×  B 
X 
  /  W–for the second transducer and (4)
Figure 16. Structure of type #3 transducer: 1—substrate; 2, 3, 4, 5—four arms of cross‐shaped figure, formed by the 
crossing of two semiconductor areas of vertical Hall transducers; 6, 7, 8, 9—current contacts; 10, 11, 12, 13—voltage 
contacts; and 14—semiconductor area of horizontal Hall transducer.
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where V(11), V(12), V(13) and V(14) are the voltages at the voltage outputs 11, 12, 13 and 
14, correspondingly; V
X
, V
Y
 and K
X
 and K
Y
—output signals and transducing coefficients of 
the first and second transducers, correspondingly; I—operational current, W—the width of 
semiconductor areas.
From the physical point of view, the appearance of voltage difference at the voltage contacts 
of the vertical Hall transducers is explained by the fact that due to the opposed current flow 
directions in both transducer arms, the deviation of current carriers in those arms has also the 
opposed direction. In particular, in arm 2 of the first transducer, the carriers are deviated in 
the direction away from the substrate to the surface of the semiconductor area, and then, in 
arm 4 of this transducer—in the direction from the surface to the substrate.
In a high‐gradient magnetic field, the voltage difference formed at the voltage outputs of the 
vertical Hall transducers is the informative value of the averaged field induction value. Taking 
into the consideration that all the voltage outputs of the vertical Hall transducers are equidis‐
tant from its center (crossing area), the measured averaged induction value corresponds to the 
spatial point of the transducer center.
The second power‐supplying mode presumes the application of only one pair of current con‐
tacts, namely 6 and 8 of the first vertical transducer. Then, output 6 is connected to the first 
power supply output, and output 8 to the second one. This provides the linear trajectory of 
the charge carriers in semiconductor area 14 of the horizontal Hall transducer.
The output signal of the horizontal Hall transducer, as a voltage difference, is proportional to 
the multiplication of the transducer power supply current by the B
Z
 projection of the magnetic 
field induction vector, formed at the voltage outputs 11 and 13 of the second vertical Hall 
transducer: V
Z
 = V(13)–V(11) = K
Z
.I.B
Z
/d
2
, where K
Z
 is the coefficient of transduction and d
2
 is 
the thickness of semiconductor area of the horizontal Hall transducer.
From the physical point of view, the appearance of the voltage difference at the voltage out‐
puts 11 and 13 is explained by the fact that charge carrier deviation in semiconductor area 14 
of the horizontal Hall transducer under the influence of B
Z
 magnetic field induction vector 
projection is in the direction from arm 5 to arm 3, or backwards.
As in the vertical transducer, the horizontal Hall transducer measures the value of the mag‐
netic field induction value in the transducer center spatial point. Thus, type #3 transducer 
allows measuring of all three projections B
X
, B
Y
 and B
Z
 of the magnetic field induction vector 
in a single spatial point.
The other distinctive feature of the type #3 transducer is the possibility to change the d
2
 thick‐
ness of the horizontal Hall transducer semiconductor area. This allows the formation of the 
transducer with equal sensitivity value to all three magnetic field induction vector projec‐
tions: V
X
/B
X
 = V
Y
/B
Y
 = V
Z
/B
Z
. Taking into consideration that the sensitivity of vertical Hall 
transducers is inversely proportional to the semiconductor area width W, and for horizontal 
transducer—to the thickness of its semiconductor area d
2
, the equality of the stated values 
of sensitivity is provided by the correspondent selection of W/d
2
 ratio. It is important that 
contrary to the d
1
 thickness of the vertical Hall transducer areas, the d
2
 thickness of the hori‐
zontal transducer semiconductor area may change after the output formation. In particular, 
the decrease of d
2
 thickness may be realized by partial etching of the semiconductor layer.
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In relation to the analogs [29], the type #3 transducer provides the increase of the measure‐
ment accuracy and construction simplification.
The increasing accuracy is caused by the fact that horizontal Hall transducer is placed in the 
center (crossing area) of vertical Hall transducer. This provides the high spatial alignment of 
all transducers (two vertical and one horizontal), and therefore, all the three projections B
X
, B
Y
 
and B
Z
 of the magnetic field induction vector are measured at a single spatial point. During 
the measurement of high‐gradient fields, this gives the ability to decrease the magnetic field 
induction vector measurement error in several times.
The third type, magnetoresistors, is mostly bipolar or field‐effect transistors whose structures 
and operating conditions are optimized with respect to the magnetic sensitivity of its output 
currents. There are three major effects of magnetotransistors, namely the current deflection 
effect, the injection modulation and the magnetodiode effect.
We have proposed the structure of magnetotransistors adapted to three dimensional sensing 
of orthogonal B
X
, B
Y
 and B
Z
 projections of the magnetic field vector (Figures 17–19). These 
are drift‐aided lateral double‐collector p‐n‐p transistors. The emitter area E and two collector 
p‐type areas C1, C2 are embedded into plate‐like n‐type base region. The two base contact n+ 
type areas B1, B2 are used to apply the bias voltage needed to establish the lateral accelerating 
electric field in the region. The emitter injects holes into the base region. Under the influence 
of the accelerating field in the base, these holes form a minority carrier beam. In the presence 
of normal B
Z
 magnetic field (Figure 17), the electric field in the base region rotates for the Hall 
angle of majority carries, and the hole beam tilts with respect to the electric field for the Hall 
Figure 17. Structure of magnetotransistor (a) and current deflection (b) I = f(B
Z
) under B
Z
 magnetic field vector projection: 
B1, B2—base contacts; E—emitter area; C1, C2—collector areas; and G–connected to ground a p‐n junction wall insulation.
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angle. The deflection of a beam leads to an imbalance in the two C1, C2 collector currents. In the 
presence of B
Y
 magnetic field vector projection (Figure 18), the hole beam tilts up to collectors 
or down toward a p− type substrate connected to ground. Doubled and quad (Figure 19) struc‐
tures are used to provide a set of signals in correspondence with three projections of magnetic 
field vector.
Based on the sensors proposed and described above, a set of magnetometers for detection and 
characterization of magnetic particles has been developed. For illustration only, an example 
of software windows for control and measurement result visualization, as well as a measure‐
ment resolution archived (in this case about 10−7T), are shown in Figures 20 and 21. As it was 
noted, the main advantage of such sensors is a possibility of measuring three orthogonal 
projections of a magnetic field vector that is quite new in characterization of magnetic particle 
technique.
Figure 19. Photos of magnetotransistors: single (a), doubled (b) and quad (c) structures.
Figure 18. Structure of magnetotransistor (a) and current deflection (b) I = f(B
Z
) under B
Z
 magnetic field vector projection: 
B1, B2 (n+ type)—base contacts; E (p type)—emitter area; C1, C2 (p type)—collector areas; G—a substrate connected to 
ground (p− type).
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3. Conclusion
It is possible to say that the interest to nanomaterials with magnetic properties increases every 
year. These materials have found their applications in medicine for diagnostics and treat‐
ment of serious diseases, where treatment by other methods is more expensive and durable. 
However, synthesis of such nanomaterials with stable properties is not completely elabo‐
rated, since besides the size factor, the character of their building microgeometry, functional 
Figure 21. Measurement resolution (noise) of magnetometer based on 3D sensors.
Figure 20. Software of magnetometer based on 3D sensors.
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properties and methods of identification should be considered. Special attention should be 
paid to sizes, topography and biocompatibility of initial nanoparticles. Just these parameters 
finally determine the functional properties.
It is shown in the paper that identification of synthesized nanoparticles can be realized most 
effectively by the change of their magnetic properties. This is possible both at the stage of 
their synthesis and after biofunctionalization. Success of the proposed approach formed the 
basis of the ideology of the Internet of Things use for monitoring the stability of nanoparticles 
microstructure and their functional properties in application in medicine.
Acknowledgements
We are infinitely grateful to Mykhailo Gonchar and Tetiana Prokopiv from the Institute of 
Cell Biology of the National Academy of Sciences of Ukraine, Department of Analytical 
Biotechnology, for kindly provided samples of Fe3O4 powders for our research. Also we 
would like to acknowledge financial support of the Ministry of Education and Science of 
Ukriaine under Grant 0116U004142  and partially by funds of 543994‐TEMPUS‐1‐2013‐1‐BE‐
TEMPUS‐JPCR MMATENG (Modernization of two cycles (MA, BA) of competence‐based 
curricula in Material Engineering according to the best experience of Bologna Process – EU).
Author details
Zoia Duriagina1*, Roman Holyaka1, Tetiana Tepla1, Volodymyr Kulyk1, Peter Arras2 and  
Elena Eyngorn3
*Address all correspondence to: zduriagina@ukr.net
1 Lviv Polytechnic National University, Lviv, Ukraine
2 KU Leuven, Sint‐Katelijne‐Waver, Belgium
3 Technische Universität Berlin, Berlin, Germany
References
[1] De Crozals G, Bonnet R, Farre C, Chaix C. Nanoparticles with multiple properties for 
biomedical applications: A strategic guide. Nano Today. 2016;11(4):435‐463
[2] Nikiforov VN. Biomedical applications of magnetic nanoparticles. Nauka i tehnologii v 
promyishlennosti. 2011;1:90‐99
[3] Filippousi M, Angelakeris M, Katsikini M, Paloura EC, Efthimiopoulos I, Wang Y, Zamboulis D, 
Van Tendeloo G. Surfactant effects on the structural and on the magnetic properties of iron oxide 
nanoparticles. Journal of Physical Chemistry C. 2014;118(29):16209‐16217. DOI: 10.1021/jp5037266
Identification of Fe3O4 Nanoparticles Biomedical Purpose by Magnetometric Methods
http://dx.doi.org/10.5772/intechopen.69717
403
[4] Uvarova IV, Maksymenko VB. Bio‐compatible Materials for Medical Products. Kyiv: 
КіМ; 2013. p. 232
[5] Fang C, Zhang M. Multifunctional magnetic nanoparticles for medical imaging applica‐
tions. Journal of Materials Chemistry. 2009;19:6258‐6266. DOI: 10.1039/B902182E
[6] Peng S, Wang C, Xie J, Sun S. Synthesis and stabilization of monodisperse Fe nanopar‐
ticles. Journal of the American Chemical Society. 2006;28:10676‐10677
[7] Gillich T, Acikgöz C, Isa L, Schlüter AD, Spencer ND, Textor M. PEG‐stabilized core‐shell 
nanoparticles: Impact of linear versus dendritic polymer shell architecture on colloidal prop‐
erties and the reversibility of temperature‐induced aggregation. ACS Nano. 2013;7:316‐329
[8] Lalatonne Y, Paris C, Serfaty JM, Weinmann P, Lecouvey M, Motte L. Bis‐phosphonates‐
ultra small superparamagnetic iron oxide nanoparticles: A platform towards diagnosis 
and therapy. Chemical Communications. 2008;22:2553‐2555
[9] Hosseini AG, Bagheri M, Mohammad‐Rezaei R. Synthesis and fluorescence stud‐
ies of dual‐responsive nanoparticles based on amphiphilic azobenzene‐contained 
poly(monomethyl itaconate). Journal of Polymer Research. 2016;23(8):12. DOI: 10.1007/
s10965‐016‐1061‐y
[10] Rozenfel’d LH, Chekman IS, Tertyshna AI. Nanotechnology in medicine, pharmacy and 
pharmacology. Farmakolohiya ta likars’ka toksykolohiya. 2008;1-3:3‐14
[11] Barrera C, Herrera AP, Bezares N, Fachini E, Olayo‐Valles R, Hinestroza JP, Rinaldi C. 
Effect of poly(ethylene oxide)‐silane graft molecular weight on the colloidal properties 
of iron oxide nanoparticles for biomedical applications. Journal of Colloid and Interface 
Science. 2012;377:40‐50
[12] Liu Y, Li Y, Li XM, He T. Kinetics of (3‐aminopropyl)triethoxylsilane (APTES) silaniza‐
tion of superparamagnetic iron oxide nanoparticle. Langmuir. 2013;29:15275‐15282
[13] Sun J, Zhou S, Hou P, Yang Y, Weng J, Li X, Li M. Synthesis and characterization of 
biocompatible Fe
3
O
4
 nanoparticles. Journal of Biomedical Materials Research Part A. 
2006;80(2):333‐341
[14] Shu Z, Wang S. Synthesis and characterization of magnetic nanosized Fe
3
O
4
/MnO
2
 com‐
posite particles. Journal of Nanomaterials. 2009;2009:340217. DOI: 10.1155/2009/340217
[15] Ahangaran F, Hassanzadeh A, Nouri S. Surface modification of Fe
3
O
4
/SiO
2
 microsphere 
by silane coupling agent. International Nano Letters. 2013;3:23
[16] Arsalani N, Fattahi H, Nazarpoor M. Synthesis and characterization of PVP‐function‐
alized superparamagnetic Fe
3
O
4
 nanoparticles as an MRI contrast agent. eXPRESS 
Polymer Letters. 2010;4(6):329‐338
[17] Husain Q. Magnetic nanoparticles as a tool for the immobilization/stabilization of hydro‐
lases and their applications: An overview. Biointerface Research in Applied Chemistry. 
2016;6(6):1585‐1606
[18] Huang HY, Lovell JF. Advanced functional nanomaterials for theranostics. Advanced 
Functional Materials. 2017;27(2):1603524. DOI: 10.1002/adfm.201603524
Biomaterials in Regenerative Medicine404
[19] Pankhurst Q, Connolly J. Applications of magnetic nanoparticles in biomedicine. Journal 
of Physics D: Applied Physics. 2003;36:167‐181
[20] Xu C, Sun S. New forms of superparamagnetic nanoparticles for biomedical applica‐
tions. Advanced Drug Delivery Reviews. 2013;65:732‐743
[21] Long NV, Thi CM, Yong Y, Cao Y, Wu H, Nogami M. Synthesis and characterization of Fe–
based metal and oxide based nanoparticles: Discoveries and research highlights of poten‐
tial applications in biology and medicine. Recent Patents on Nanotechnology. 2014;8:52‐61
[22] Huang DJ, Lin H‐J, Okamoto J, Chao KS, Jeng H‐T, Guo GY, Hsu C‐H, Huang C‐M, 
Ling DC, Wu WB, Yang CS, Chen CT. Charge‐orbital ordering and Verwey transition 
in magnetite measured by resonant soft X‐ray scattering. Physical Review Letters. 
2006;96(9):096401. DOI: 10.1103/PhysRevLett.96.096401
[23] Radisavljevic I, Kuzmanovic B, Novakovic N, Mahnke HE, Vulicevic LJ, Kurko S, 
Ivanovic N. Structural stability and local electronic properties of some EC synthesized 
magnetite nanopowders. Journal of Alloys and Compounds. 2017;697:409‐416. DOI: 
10.1016/j.jallcom.2016.11.090
[24] Nikiforov VN, Ignatenko AN, Irhin VY. The magnetism of the magnetite nanoparticles: 
Effects of finite size and coating. Izvestiya RAN. Seriya fizicheskaya. 2014;78(10):1336‐1340. 
DOI: 10.7868/S0367676514100159
[25] Duriagina ZA, Holyaka RL, Borysyuk AK. Automated widely diapazon magnetom‐
eter for magnetic alloys phase analysis: Development and application. Uspehi Fiziki 
Metallov; 2013;14:33‐66
[26] Kondyr AI, Borysyuk AK, Pazdriy IP, Shvachko SH. The use of a vibrating magnetom‐
eter for phase analysis of special steels and alloys. Vybratsyy v tekhnyke y tekhnolo‐
hyyakh. 2004;34(2):41
[27] Koh I, Josephson L. Magnetic nanoparticle sensors. Sensors. 2009;9:8130‐8145. DOI: 
10.3390/s91008130
[28] Janssen XJA, van Ijzendoorn LJ, Prins MWJ. On‐chip manipulation and detection of mag‐
netic particles for functional biosensors. Biosensors and Bioelectronics. 2008;23:833‐838. 
DOI: 10.1016/j.bios.2007.08.023
[29] Popovic RS. Hall Effect Devices. CAT# IPE331. 2nd ed. Bristol and Philadelphia, 
USA;CRC Press, 2003. p. 420. ISBN: 9780750308557. Available from: https://www.crc‐
press.com/Hall‐Effect‐Devices‐Second‐Edition/Popovic/p/book/9780750308557
[30] Popovic DR, Dimitrijevic S, Blagojevic M, Kejik P, Schurig E, Popovic RS. Three‐axis 
teslameter with integrated Hall probe. IEEE Transactions on Instrumentations and 
Measurement. 2007;56(4):1396‐1402. DOI: 10.1109/TIM.2007.900133
[31] wikipedia.org. Magnetoresistance [Internet]. Available from: https://en.wikipedia.org/
wiki/Magnetoresistance
[32] honeywell.com. 3‐Axis Digital Compass IC HMC5883L [Internet]. 2010. Available from: 
https://aerocontent.honeywell.com/aero/common/documents/myaerospacecatalog‐doc‐
uments/Defense_Brochures‐documents/HMC5843.pdf
Identification of Fe3O4 Nanoparticles Biomedical Purpose by Magnetometric Methods
http://dx.doi.org/10.5772/intechopen.69717
405
[33] Bolshakova I, Holyaka R. Multiposition 3‐D Magnetic Field Sensor [Internet]. European 
Patent Office, Patent No. WO2005029604. 2005. Available from: https://worldwide.
espacenet.com/searchResults?ST=singleline&locale=en_EP&submitted=true&DB=&que
ry=WO2005029604
[34] Bolshakova I, Holyaka R. Method for Measuring Magnetic Field [Internet]. European 
Patent Office, Patent No. WO2012054000. 2012. Available from: https://worldwide.
espacenet.com/searchResults?ST=singleline&locale=en_EP&submitted=true&DB=&que
ry=WO2012054000
[35] Bolshakova I, Holyaka R. Magnetic Field Measuring Sensor [Internet]. European Patent 
Office, Patent No. WO2006028425. 2006. Available from: https://worldwide.espacenet.
com/searchResults?ST=singleline&locale=en_EP&submitted=true&DB=&query
=WO2006028425
[36] Bolshakova I, Holyaka R. Magnetic Field Measuring Sensor [Internet]. European Patent 
Office, Patent No. WO2006028427. 2006. Available from: https://worldwide.espacenet.
com/searchResults?ST=singleline&locale=en_EP&submitted=true&DB=&query
=WO2006028427
[37] Bolshakova I, Holyaka R. Magnetic Field Measuring Sensor [Internet]. European Patent 
Office, Patent No. WO2006028426. 2006. Available from: https://worldwide.espacenet.
com/searchResults?ST=singleline&locale=en_EP&submitted=true&DB=&query
=WO2006028426
[38] Bolshakova I, Holyaka R, Murari A. Method for Measuring Magnetic Field [Internet]. 
European Patent Office, Patent No. EP2630511. 2015. Available from: https://worldwide.
espacenet.com/searchResults?ST=singleline&locale=en_EP&submitted=true&DB=&que
ry=EP2630511
[39] Bolshakova I, Holyaka R, Gerasimov S. Magnetic Field Measurement with Continuous 
Calibration [Internet]. European Patent Office, Patent No. GB2427700. 2009. Available 
from: https://worldwide.espacenet.com/searchResults?ST=singleline&locale=en_EP& 
submitted=true&DB=&query=GB2427700
[40] Hotra Z, Holyaka R, Marusenkova T, Ilkanych V. Algorithms of semiconductor magnetic 
field sensor devices power consumption minimization. In: ELNANO; 2012; Kyiv. pp. 
29‐30. Available from: http://journals.kpi.ua/publications/text/29_30_2012.pdf
[41] Hotra Z, Holyaka R, Marusenkova T. Optimization of microelectronic magnetic 
sensors on the splitted Hall structures. In: Prace Instytutu Elektrotechniki, editor. 
Proceedings of Electrotechnical Institute, Instytut Elektrotechniki. Issue 247. 2010. 
pp. 13‐18. Available from: https://pbn.nauka.gov.pl/polindex‐webapp/browse/article/
article‐4d222aa0‐9679‐45e1‐9467‐5c5de8b262f6
[42] Hotra Z, Holyaka R, Bolshakova I, Yurchak I, Marusenkova T. Spatial models of split‐
ted Hall structures. In: Proceedings of VIIth International Conferenceon Perspective 
Technologies and Methods in MEMS Design; MEMSTECH–2011; IEEE.2011. pp. 5‐8. 
Available from: http://ieeexplore.ieee.org/document/5960249/
Biomaterials in Regenerative Medicine406
[43] Holyaka R, Yurchak I, Marusenkova T, Ilkanych V. Microprocessor noise‐immune sig‐
nal transducer for galvanomagnetic smart sensor devices. In: International Conferenceon 
Modern Problems of Radio Engineering Telecommunications and Computer Science; 
TCSET–2012; IEEE.2012. p. 430. Available from: http://ieeexplore.ieee.org/document/619 
2682/
[44] Bolshakova I, Holyaka R, Hotra Z, Marusenkova T. Methods of modeling and calibrating 
3D magnetic sensors based on splitted Hall structures. Electronics and Nanotechnologies. 
Proceedings of the XXXI International Scientific Conference. 2011; p. 38. Available from: 
http://www.journals.kpi.ua/publications/text/2011_38.pdf
Identification of Fe3O4 Nanoparticles Biomedical Purpose by Magnetometric Methods
http://dx.doi.org/10.5772/intechopen.69717
407

